Orange Book product · Generic (ANDA)
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
At a glance
Oct 26, 2016
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 26, 2016
9 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Strength
12.5MG;20MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 078827
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- 2003BENICAR HCTBrand (NDA)
NDA 021532 · COSETTE
- 2026OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 206371 · MICRO LABS
- 2026OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 208465 · SCIEGEN PHARMS
- 2025OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 217398 · MSN
- 2025OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 214427 · HANGZHOU BINJIANG
- 2025OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 209199 · HETERO LABS LTD V
- 2024OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 207037 · ALKEM LABS LTD
- 2023OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 204801 · MACLEODS PHARMS LTD
- 2023OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 206377 · ZYDUS PHARMS
- 2019OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 208847 · UMEDICA
- 2019OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 209281 · ACCORD HLTHCARE
- 2017OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 206515 · TORRENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
